Article Details

Summary of Sage Therapeutics, Inc. (NASDAQ:SAGE) Ratings as of Apr 22, 2018

Retrieved on: 2018-04-22 03:42:55

Tags for this article:

Click the tags to see associated articles and topics

Summary of Sage Therapeutics, Inc. (NASDAQ:SAGE) Ratings as of Apr 22, 2018. View article details on hiswai:

Excerpt

<div><b>Aqr Capital Management</b> Limited Liability Com holds 0.01% of its capital in Sage Therapeutics, Inc. (NASDAQ:SAGE) for 48,010 shs. Glob X Management Com Lc holds 318 shs. Kingdon Capital Management Lc reported 130,516 shs. Deutsche National Bank & Trust Ag has 0.02% invested in Sage ...</div>

Article found on:

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up